Several tumor types, particularly breast, ovarian, pancreatic, and prostate cancer, exhibited a strong correlation between elevated gLOH and biallelic alterations in multiple key HRR genes beyond BRCA1 and BRCA2. The gene discussed is BRCA1; the disease is prostate carcinoma.